Knowledge Distillery

Little is known regarding long-term outcomes of patients hospitalized with COVID-19.

The Pfizer-BioNTech (BNT162b2) and the Oxford-AstraZeneca (ChAdOx1 nCoV-19) COVID-19 vaccines have shown excellent safety and efficacy in phase 3…

Estimating rates of COVID-19 infection and associated mortality is challenging due to uncertainties in case ascertainment.

This prospective cohort study enrolled 8 hospitalized COVID-19 patients and assessed them at subacute and chronic stage (after 6 months) with MoCA and…

This retrospective cohort study used the TriNetX electronic health records network, which has over 81 million patients’ data, to estimate the…

Evidence is urgently needed to support treatment decisions for children with multisystem inflammatory syndrome (MIS-C) associated with severe acute…

The assessment of real-world effectiveness of immunomodulatory medications for multisystem inflammatory syndrome in children (MIS-C) may guide…

The efficacy and safety of tofacitinib, a Janus kinase inhibitor, in patients who are hospitalized with coronavirus disease 2019 (COVID-19) pneumonia…

The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental and early clinical data…

SARS-CoV-2 entry in human cells depends on angiotensin-converting enzyme 2, which can be upregulated by inhibitors of the renin–angiotensin system…

COVID-19 is associated with a prothrombotic state leading to adverse clinical outcomes. Whether therapeutic anticoagulation improves outcomes in…

Adolescence represents a crucial developmental period in shaping mental health trajectories. In this longitudinal, population-based study the authors…